Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacidipine in Hypertensive Patients with Type 2 Diabetes
NCT00328965Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2004
- Primary completion
- May 2006
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of lacidipine in essential hypertension, sponsored by GSK. Started Nov 2004; status: completed.
02
Drugs
lacidipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00328965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328965.